Schering Reinspection Brings New FDA-483s: Firm Updates Compliance Plans
Executive Summary
FDA has issued FDA-483 reports to Schering-Plough following recent reinspections of its manufacturing operations in Puerto Rico and New Jersey, the company disclosed June 22.